| The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location I Liu, L Jiang, ER Samuelsson, S Marco Salas, A Beck, OA Hack, D Jeong, ... Nature Genetics 54 (12), 1881-1894, 2022 | 57 | 2022 |
| PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation P Khadka, ZJ Reitman, S Lu, G Buchan, G Gionet, F Dubois, DM Carvalho, ... Nature communications 13 (1), 604, 2022 | 26 | 2022 |
| Structural variants shape driver combinations and outcomes in pediatric high-grade glioma FPB Dubois, O Shapira, NF Greenwald, T Zack, J Wala, JW Tsai, A Crane, ... Nature cancer 3 (8), 994-1011, 2022 | 19 | 2022 |
| Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatment JW Tsai, JJ Choi, H Ouaalam, EA Murillo, KK Yeo, J Vogelzang, C Sousa, ... Neuro-Oncology Advances 5 (1), vdac182, 2023 | 11 | 2023 |
| Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics KK Yeo, S Alexandrescu, JA Cotter, J Vogelzang, V Bhave, MM Li, J Ji, ... Neuro-oncology 25 (1), 199-210, 2023 | 9 | 2023 |
| Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma S Tobochnik, E Lapinskas, J Vogelzang, KL Ligon, JW Lee Journal of neuro-oncology 159 (1), 211-218, 2022 | 9 | 2022 |
| FOXR2 is an epigenetically regulated pan-cancer oncogene that activates ETS transcriptional circuits JW Tsai, P Cejas, DK Wang, S Patel, DW Wu, P Arounleut, X Wei, N Zhou, ... Cancer research 82 (17), 2980-3001, 2022 | 8 | 2022 |
| Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma DA Hofman, J Ruiz-Orera, I Yannuzzi, R Murugesan, A Brown, ... Molecular Cell 84 (2), 261-276. e18, 2024 | 5 | 2024 |
| Glioma genetic profiles associated with electrophysiologic hyperexcitability S Tobochnik, MKC Dorotan, HS Ghosh, E Lapinskas, J Vogelzang, ... Neuro-oncology 26 (2), 323-334, 2024 | 4 | 2024 |
| ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma AF Blandin, R Giglio, MS Graham, G Garcia, S Malinowski, JK Woods, ... Clinical Cancer Research 29 (14), 2651-2667, 2023 | 4 | 2023 |
| Clinical trial enrollment among adolescent and young adults with primary central nervous system tumors treated at the Dana-Farber cancer institute S Sarvode, JR Vogelzang, S Sarvode Mothi, KE Warren, DA Reardon, ... Journal of Adolescent and Young Adult Oncology 11 (6), 543-549, 2022 | 2 | 2022 |
| MDB-32. TRANSLATION OF NON-CANONICAL OPEN READING FRAMES AS A CANCER CELL SURVIVAL MECHANISM IN CHILDHOOD MEDULLOBLASTOMA D Hofman, J Ruiz-Orera, I Yannuzzi, R Murugesan, J van Dinter, ... Neuro-Oncology 25 (Suppl 1), i69, 2023 | 1 | 2023 |
| EPID-11. A multi-institutional comparative analysis of the clinical, genomic, and survival characteristics of pediatric, young adult and older adult patients with idh-mutant glioma M Jane Lim-Fat, J Vogelzang, E Woodward, A McGovern, C Ma, ... Neuro-Oncology 22 (Supplement_2), ii80-ii81, 2020 | 1 | 2020 |
| DDDR-09. FUNCTIONAL GENOMICS AND CHEMOTHERAPY RESISTANCE SCREENING IDENTIFIES BIOMARKERS AND TARGETABLE MECHANISMS OF CCNU RESISTANCE IN GLIOMAS C Hajal, S Dalin, G Raskind, M Cusick, S Malinowski, J Ito, C Bossi, ... Neuro-Oncology 25 (Supplement_5), v106-v107, 2023 | | 2023 |
| TMIC-11. SPATIAL PROFILING OF TUMOR VASCULATURE AT AUTOPSY IN BRAINSTEM GLIOMAS J Straehla, J Woods, J Vogelzang, J Jones, K Ligon, S Alexandrescu Neuro-Oncology 25 (Supplement_5), v280-v280, 2023 | | 2023 |
| DIPG-20. DELINEATING MEDIATORS OF ONCOGENESIS IN FOXR2-EXPRESSING DIFFUSE MIDLINE GLIOMAS J Tsai, P Cejas, M Coppola, D Wang, S Patel, D Wu, P Arounleut, X Wei, ... Neuro-Oncology 25 (Supplement_1), i17-i17, 2023 | | 2023 |
| DIPG-08. THE LANDSCAPE OF TUMOR CELL STATES AND SPATIAL ORGANIZATION IN H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA ACROSS AGE AND LOCATION I Liu, L Jiang, E Samuelsson, SM Salas, A Beck, O Hack, D Jeong, ... Neuro-Oncology 25 (Supplement_1), i14-i14, 2023 | | 2023 |
| Dissecting mechanisms underlying FOXR2-mediated gliomagenesis in diffuse midline gliomas JW Tsai, P Cejas, M Coppola, DK Wang, S Patel, DW Wu, P Arounleut, ... Cancer Research 83 (7_Supplement), 3562-3562, 2023 | | 2023 |
| Molecular Landscape and Contemporary Prognostic Signatures of Gliomas HS Ghosh, RV Patel, E Woodward, NF Greenwald, VM Bhave, EA Maury, ... medRxiv, 2023.09. 09.23295096, 2023 | | 2023 |
| PATH-15. THE PROGNOSTIC IMPLICATION OF MGMT PROMOTER METHYLATION IN IDH-MUTANT GLIOMAS G Youssef, E Aquilanti, A Muzikansky, J Miller, J Vogelzang, E Lapinskas, ... Neuro-Oncology 24 (Supplement_7), vii153-vii153, 2022 | | 2022 |
